Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-874 vs methotrexate in moderate to severe chronic plaque psoriasis
2007-004687-47Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of briakinumab in psoriasis (2 arms), sponsored by Abbott Laboratories. Primary endpoint: PASI 75 response at Week 24. Started Nov 2007; status: completed.
02
Drugs
briakinumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2007-004687-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004687-47.